欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/V/0171/002
药品名称Spizobactin-M
活性成分
    • METRONIDAZOLE 250.0 mg
    • SPIRAMYCIN 1500000.0 IU
剂型Tablet
上市许可持有人Le Vet Beheer B.V.
参考成员国 - 产品名称Germany (DE)
Spizobactin
互认成员国 - 产品名称
    • Denmark (DK)
      Spizobactin Vet.
    • Belgium (BE)
      Spizobactin 1 500 000 IE / 250 mg
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Spizobactin-M 1.500.000 a.e. / 250 mg tuggutafla handa hundum
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Spizobactin 1.500.000 IE / 250 mg Kautabletten für Hunde
    • France (FR)
      SPIZOBACTIN-M COMPRIMES A CROQUER POUR CHIENS (14448)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
      Spizobactin vet
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      Spizobactin vet
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      Spizobactin 1 500 000 IU / 250 mg žvýkací tablety pro psy
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2017/06/28
最近更新日期2025/08/04
药物ATC编码
    • QJ01RA91 macrolides, combinations with other antibacterials
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase